Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Greenland Lithium Pegmatite Field Significantly Expanded by Brunswick Exploration August 13, 2025 International Lithium Announces Private Placement August 13, 2025 Rio Silver Amends Maria Norte Terms August 13, 2025